These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 364284)

  • 21. BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
    Durant JR; Gams RA; Bartolucci AA; Dorfman RF
    Cancer Treat Rep; 1977 Sep; 61(6):1085-96. PubMed ID: 332345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
    Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
    Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
    Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
    Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-intensity analysis for CHOP chemotherapy in diffuse aggressive large cell lymphoma.
    Epelbaum R; Haim N; Ben-Shahar M; Ron Y; Cohen Y
    Isr J Med Sci; 1988; 24(9-10):533-8. PubMed ID: 3060443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
    Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
    Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
    Bonadonna G; Monfardini S; Villa E
    Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination chemotherapy of non-Hodgkin lymphoma.
    Forcier RJ; McIntyre OR; Nissen NI; Pajak TF; Glidewell O; Holland JF
    Med Pediatr Oncol; 1978; 4(4):351-62. PubMed ID: 364285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas.
    Monfardini S; Tancini G; DeLena M; Villa E; Valagussa P; Bonadonna G
    Med Pediatr Oncol; 1977; 3(1):67-74. PubMed ID: 65728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
    Arai N; Hara A; Kaneko H; Umeda M; Shirai T
    Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy of the malignant lymphomas: a controlled clinical trial.
    Lenhard RE; Prentice RL; Owens AH; Bakemeier R; Horton JH; Shnider BI; Stolbach L; Berard CW; Carbone PP
    Cancer; 1976 Sep; 38(3):1052-9. PubMed ID: 782685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of rituximab plus CHOP regimen and CHOP regimen alone for treatment of newly diagnosed patients with diffuse large B-cell lymphoma].
    Wu HJ; Zhang QY; Chen DF; Guan XJ; Zhang BL; Ma J
    Ai Zheng; 2005 Dec; 24(12):1498-502. PubMed ID: 16351800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
    Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
    Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.
    Vaccher E; Spina M; di Gennaro G; Talamini R; Nasti G; Schioppa O; Vultaggio G; Tirelli U
    Cancer; 2001 Jan; 91(1):155-63. PubMed ID: 11148572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced diffuse histiocytic lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) without maintenance therapy.
    Armitage JO; Corder MP; Leimert JT; Dick FR; Elliot TE
    Cancer Treat Rep; 1980; 64(4-5):649-54. PubMed ID: 7000347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma.
    Newcomer LN; Cadman EC; Nerenberg MI; Chen M; Bertino JR; Farber LR; Prosnitz LR
    Cancer Treat Rep; 1982 Jun; 66(6):1279-84. PubMed ID: 6177407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma. A comparison of doxorubicin and pirarubicin: a randomized phase II study.
    Tsurumi H; Yamada T; Sawada M; Kasahara S; Kanemura N; Kojima Y; Fukuno K; Hara T; Saio M; Takahashi T; Oyama M; Ozawa K; Takami T; Moriwaki H
    J Cancer Res Clin Oncol; 2004 Feb; 130(2):107-13. PubMed ID: 14648210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
    Hara T; Yoshikawa T; Goto H; Sawada M; Yamada T; Fukuno K; Kasahara S; Shibata Y; Matsumoto T; Mabuchi R; Nakamura N; Nakamura H; Ninomiya S; Kitagawa J; Kanemura N; Nannya Y; Katsumura N; Takahashi T; Kito Y; Takami T; Miyazaki T; Takeuchi T; Shimizu M; Tsurumi H
    Hematol Oncol; 2018 Oct; 36(4):638-644. PubMed ID: 29882279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemotherapy of advanced non-Hodgkin lymphomas: a report of 35 cases.
    Büchi G; Mazza U; Camaschella C; Saglio G; Cambrin GR; Termine G; Enrico E; Autino R; Zappala C
    Tumori; 1982 Aug; 68(4):307-11. PubMed ID: 6897306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.